First AD

Second AD

Prostate Cancer

The OncLive Prostate Cancer condition center page is a comprehensive resource for clinical news and expert insights on how to approach treatment for patients with nonmetastatic, castration-resistant, or castration-sensitive prostate cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, ongoing research, and treatment advances with androgen receptor inhibitors, PARP inhibitors, and more in prostate cancer.

Advanced Prostate Cancer: PSMA-Targeted Radioligand Therapies

OncLive News Network®

Neal Shore, MD, discusses the complexity of prostrate cancer and factors to consider when determining management strategies. 

Prostate Cancer Disease Complexity and Testing

Genotypic and Phenotypic Biomarkers in Prostate Cancer

Diagnostic and Therapeutic Applications of PSMA in Prostate Cancer 

Use of PSMA PET Scans in Advanced Prostate Cancer

The VISION Study of 177Lu-PSMA-617 in mCRPC  

Future Directions With PSMA Ligand–Directed Therapies  